...
机译:编程的死亡-1(PD-1)受体/ PD-1配体(PD-L1)在富马酸盐水合酶缺乏肾细胞癌中的表达
Department of Pathology Faculty of Medicine University of British Columbia Royal Columbian;
Department of Pathology Charles University Medical Faculty and Charles University Hospital Plzen;
Calgary Laboratory Services University of Calgary;
Robert J. Tomsich Pathology and Laboratory Medicine Institute Cleveland Clinic;
Department of Pathology Bellvitge Biomedical Research Institute (IDIBELL);
Department of Pathology Bellvitge Biomedical Research Institute (IDIBELL);
Bart's Cancer Center;
Hospital Cochin;
Department of Pathology Medical College Wisconsin;
Department of Pathology University Erlangen;
Department of Pathology Instituto Nacional de Cancerologia;
Department of Pathology Charles University Medical Faculty and Charles University Hospital Plzen;
Department of Pathology Charles University Medical Faculty and Charles University Hospital Plzen;
Department of Pathology Charles University Medical Faculty and Charles University Hospital Plzen;
Department of Pathology Charles University Medical Faculty and Charles University Hospital Plzen;
Department of Pathology Charles University Medical Faculty and Charles University Hospital Plzen;
Department of Pathology Charles University Medical Faculty and Charles University Hospital Plzen;
Department of Urology Charles University Medical Faculty and Charles University Hospital Plzen;
Department of Pathology Charles University Medical Faculty and Charles University Hospital Plzen;
Department of Pathology Charles University Medical Faculty and Charles University Hospital Plzen;
Kidney; Fumarate hydratase-deficient renal cell carcinoma; Programmed death-1 (PD-1) receptor; PD-1 ligand (PD-L1) receptor;
机译:编程的死亡-1(PD-1)受体/ PD-1配体(PD-L1)在富马酸盐水合酶缺乏肾细胞癌中的表达
机译:肿瘤微环境中CD8 +和CD25 +程序性细胞死亡1(PD-1)配体(PD-L1)CD4 + T细胞的可变密度导致对PD-1 / PD-L1封锁的不同反应
机译:在非小细胞肺癌中编程死亡-1受体(PD-1)和PD-LigAnd-1(PD-L1)表达和厌氧糖醇的免疫抑制作用
机译:免疫检查点的分子动力学程序性细胞死亡蛋白I,PD-1:配体PD-L1与单克隆抗体nivolumab结合后BC环的构象变化
机译:表征PD-1配体PD-L1和PD-L2在调节T细胞对流感病毒的反应中的作用。
机译:肿瘤微环境中CD8 +和CD25 +程序性细胞死亡1(PD-1)配体(PD-L1)CD4 + T细胞的可变密度导致对PD-1 / PD-L1阻断的不同反应
机译:肿瘤微环境中CD8 +和CD25 +程序性细胞死亡1(PD-1)配体(PD-L1)CD4 + T细胞的可变密度导致对PD-1 / PD-L1阻断的不同反应